PTIE
Pain Therapeutics, Inc.
A biopharmaceutical company that developed pain medications, founded in 1998 by Remi Barbier in South San Francisco, California. It worked on drugs like Remoxy, an extended-release opioid designed to be thick and sticky so it could not easily be crushed or dissolved for abuse, and Oxytrex for pain. In 2019 the company rebranded as Cassava Sciences to shift focus to Alzheimer's treatments, and it now operates as Filana Therapeutics.
CUSIP: 69562K506HealthcareUS1 holder
Total Value
$6.64M
Total Shares
936.1K
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
